Phosphatidylinositides	O
bind	O
to	O
plasma	B-protein
membrane	I-protein
CD14	I-protein
and	O
can	O
prevent	O
monocyte	O
activation	O
by	O
bacterial	O
lipopolysaccharide	O
.	O

Although	O
bacterial	O
lipopolysaccharides	O
(	O
LPS	O
)	O
and	O
several	O
other	O
microbial	O
agonists	O
can	O
bind	O
to	O
mCD14	B-protein
(	O
membrane	B-protein
CD14	I-protein
)	O
,	O
a	O
cell-surface	O
receptor	O
found	O
principally	O
on	O
monocytes	B-cell_type
and	O
neutrophils	B-cell_type
,	O
host-derived	O
mCD14	B-protein
ligands	O
are	O
poorly	O
defined	O
.	O

We	O
report	O
here	O
that	O
phosphatidylinositol	O
(	O
PtdIns	O
)	O
,	O
phosphatidylinositol-4-phosphate	O
,	O
and	O
other	O
phosphatidylinositides	O
can	O
bind	O
to	O
mCD14	B-protein
.	O

Phosphatidylserine	O
(	O
PS	O
)	O
,	O
another	O
anionic	O
glycerophospholipid	O
,	O
binds	O
to	O
mCD14	B-protein
with	O
lower	O
apparent	O
affinity	O
than	O
does	O
PtdIns	O
.	O

LPS-binding	B-protein
protein	I-protein
,	O
a	O
lipid	O
transfer	O
protein	O
found	O
in	O
serum	O
,	O
facilitates	O
both	O
PS	O
-and	O
PtdIns-	O
mCD14	B-protein
binding	O
.	O

PtdIns	O
binding	O
to	O
mCD14	B-protein
can	O
be	O
blocked	O
by	O
anti-CD14	B-protein
monoclonal	I-protein
antibodies	I-protein
that	O
inhibit	O
LPS	O
-mCD14	B-protein
binding	O
,	O
and	O
PtdIns	O
can	O
inhibit	O
both	O
LPS	O
-mCD14	B-protein
binding	O
and	O
LPS-induced	O
responses	O
in	O
monocytes	B-cell_type
.	O

Serum-equilibrated	B-cell_type
PtdIns	I-cell_type
also	I-cell_type
binds	I-cell_type
to	I-cell_type
mCD14-expressing	I-cell_type
cells	I-cell_type
,	O
raising	O
the	O
possibility	O
that	O
endogenous	O
PtdIns	O
may	O
modulate	O
cellular	O
responses	O
to	O
LPS	O
and	O
other	O
mCD14	B-protein
ligands	O
in	O
vivo	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

38	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
18	NULL
,	NULL
pp	NULL
.	NULL

24309-24313	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Phosphatidylinositides	NULL
Bind	NULL
to	NULL
Plasma	NULL
Membrane	NULL
CD14	NULL
and	NULL
Can	NULL
Prevent	NULL
Monocyte	NULL
Activation	NULL
by	NULL
Bacterial	NULL
Lipopolysaccharide*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
June	NULL
4	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
July	NULL
29	NULL
,	NULL
1998	NULL
)	NULL
Ping-yuan	NULL
Wang	NULL
#	NULL
§	NULL
,	NULL
Richard	NULL
L.	NULL
Kitchens	NULL
}	NULL
,	NULL
and	NULL
Robert	NULL
S.	NULL
Munford	NULL
$	NULL
§	NULL
]	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Internal	NULL
Medicine	NULL
and	NULL
Microbiology	NULL
and	NULL
the	NULL
§Cell	NULL
Regulation	NULL
Graduate	NULL
Program	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
Texas	NULL
75235-9113	NULL
Although	NULL
bacterial	NULL
lipopolysaccharides	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
several	NULL
other	NULL
microbial	NULL
agonists	NULL
can	NULL
bind	NULL
to	NULL
mCD14	NULL
(	NULL
mem-brane	NULL
CD14	NULL
)	NULL
,	NULL
a	NULL
cell-surface	NULL
receptor	NULL
found	NULL
principally	NULL
on	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
,	NULL
host-derived	NULL
mCD14	NULL
ligands	NULL
are	NULL
poorly	NULL
defined	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
phosphatidylinositol	NULL
(	NULL
PtdIns	NULL
)	NULL
,	NULL
phosphatidylinositol-4-phos-phate	NULL
,	NULL
and	NULL
other	NULL
phosphatidylinositides	NULL
can	NULL
bind	NULL
to	NULL
mCD14	NULL
.	NULL

Phosphatidylserine	NULL
(	NULL
PS	NULL
)	NULL
,	NULL
another	NULL
anionic	NULL
glyc-erophospholipid	NULL
,	NULL
binds	NULL
to	NULL
mCD14	NULL
with	NULL
lower	NULL
apparent	NULL
affinity	NULL
than	NULL
does	NULL
PtdIns	NULL
.	NULL

LPS-binding	NULL
protein	NULL
,	NULL
a	NULL
lipid	NULL
transfer	NULL
protein	NULL
found	NULL
in	NULL
serum	NULL
,	NULL
facilitates	NULL
both	NULL
PS-	NULL
and	NULL
PtdIns-mCD14	NULL
binding	NULL
.	NULL

PtdIns	NULL
binding	NULL
to	NULL
mCD14	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
anti-CD14	NULL
monoclonal	NULL
antibodies	NULL
that	NULL
inhibit	NULL
LPS-mCD14	NULL
binding	NULL
,	NULL
and	NULL
PtdIns	NULL
can	NULL
inhibit	NULL
both	NULL
LPS-mCD14	NULL
binding	NULL
and	NULL
LPS-induced	NULL
responses	NULL
in	NULL
monocytes	NULL
.	NULL

Serum-equilibrated	NULL
PtdIns	NULL
also	NULL
binds	NULL
to	NULL
mCD14-expressing	NULL
cells	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
endogenous	NULL
PtdIns	NULL
may	NULL
modulate	NULL
cellular	NULL
responses	NULL
to	NULL
LPS	NULL
and	NULL
other	NULL
mCD14	NULL
ligands	NULL
in	NULL
vivo	NULL
.	NULL

Responses	NULL
of	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
to	NULL
low	NULL
concentrations	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
``	NULL
a	NULL
bacterial	NULL
glycophospho-lipid	NULL
,	NULL
occur	NULL
after	NULL
LPS	NULL
molecules	NULL
bind	NULL
to	NULL
mCD14	NULL
,	NULL
a	NULL
glycosylphos-phatidylinositol	NULL
(	NULL
GPT	NULL
)	NULL
-anchored	NULL
plasma	NULL
membrane	NULL
protein	NULL
.	NULL

mCD14	NULL
can	NULL
bind	NULL
exogenous	NULL
molecules	NULL
as	NULL
diverse	NULL
in	NULL
structure	NULL
as	NULL
peptidoglycan	NULL
(	NULL
1	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
lipoarabinomannan	NULL
(	NULL
4	NULL
)	NULL
,	NULL
Bor-relia	NULL
lipopeptides	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
several	NULL
polysaccharides	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Although	NULL
endogenous	NULL
(	NULL
host-derived	NULL
)	NULL
mCD14	NULL
ligands	NULL
are	NULL
not	NULL
so	NULL
well	NULL
un-derstood	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
soluble	NULL
CD14	NULL
(	NULL
sCD14	NULL
)	NULL
,	NULL
the	NULL
anchor-less	NULL
form	NULL
of	NULL
CD14	NULL
,	NULL
can	NULL
function	NULL
as	NULL
a	NULL
lipid	NULL
transfer	NULL
protein	NULL
,	NULL
moving	NULL
both	NULL
LPS	NULL
and	NULL
phospholipids	NULL
to	NULL
lipoproteins	NULL
and	NULL
other	NULL
acceptors	NULL
(	NULL
7	NULL
)	NULL
.	NULL

A	NULL
plasma	NULL
protein	NULL
,	NULL
LPS-binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
,	NULL
greatly	NULL
facilitates	NULL
ligand	NULL
binding	NULL
to	NULL
both	NULL
soluble	NULL
and	NULL
membrane	NULL
CD14	NULL
(	NULL
8	NULL
)	NULL
.	NULL

LBP	NULL
can	NULL
also	NULL
catalyze	NULL
the	NULL
transfer	NULL
of	NULL
various	NULL
lipids	NULL
to	NULL
sCD14	NULL
(	NULL
7	NULL
)	NULL
and	NULL
to	NULL
phospholipid-cholesterol	NULL
artificial	NULL
membranes	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Although	NULL
its	NULL
phospholipid-binding	NULL
properties	NULL
have	NULL
not	NULL
been	NULL
detailed	NULL
,	NULL
mCD14	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
macrophage	NULL
recognition	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
and	NULL
an	NULL
ability	NULL
to	NULL
bind	NULL
anionic	NULL
phospholipids	NULL
on	NULL
these	NULL
cells	NULL
has	NULL
been	NULL
inferred	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
AI18188	NULL
from	NULL
the	NULL
NIAID	NULL
and	NULL
Grant	NULL
AR41940	NULL
from	NULL
the	NULL
NIAMS	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
University	NULL
or	NULL
Texas-Southwestern	NULL
,	NULL
5828	NULL
Harry	NULL
Hines	NULL
Blvd	NULL
.	NULL

,	NULL
Dallas	NULL
,	NULL
TX	NULL
75235-9118	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
214-648-3480	NULL
;	NULL
Fax	NULL
:	NULL
214-648-9478	NULL
;	NULL
E-mail	NULL
:	NULL
rmunfl	NULL
@	NULL
mednet.swmed.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
mCD14	NULL
,	NULL
membrane	NULL
CD14	NULL
;	NULL
sCD14	NULL
,	NULL
soluble	NULL
CD14	NULL
;	NULL
LBP	NULL
,	NULL
LPS-binding	NULL
protein	NULL
;	NULL
GPI	NULL
,	NULL
glycosylphosphatidylinositol	NULL
;	NULL
PtdIns	NULL
,	NULL
phosphatidylinositol	NULL
;	NULL
PS	NULL
,	NULL
phos-phatidylserine	NULL
;	NULL
PC	NULL
,	NULL
phosphatidylcholine	NULL
;	NULL
PE	NULL
,	NULL
phosphatidylethanolamine	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
ELISA	NULL
,	NULL
enzyme-linked	NULL
immunosorbent	NULL
as-say	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
Phosphatidylinositol	NULL
(	NULL
PtdIns	NULL
)	NULL
,	NULL
an	NULL
anionic	NULL
glycerophospho-lipid	NULL
,	NULL
is	NULL
a	NULL
precursor	NULL
for	NULL
several	NULL
prominent	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
.	NULL

It	NULL
is	NULL
present	NULL
in	NULL
low	NULL
(	NULL
50-100	NULL
um	NULL
)	NULL
concentrations	NULL
in	NULL
plasma	NULL
(	NULL
13-16	NULL
)	NULL
,	NULL
where	NULL
it	NULL
seems	NULL
to	NULL
be	NULL
largely	NULL
bound	NULL
to	NULL
lipoproteins	NULL
(	NULL
high	NULL
density	NULL
lipoprotein	NULL
>	NULL
low	NULL
density	NULL
lipoprotein	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
macrophages	NULL
to	NULL
take	NULL
up	NULL
phospholipid-rich	NULL
liposomes	NULL
has	NULL
been	NULL
appreciated	NULL
for	NULL
many	NULL
years	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
and	NULL
recent	NULL
reports	NULL
indicate	NULL
that	NULL
both	NULL
PtdIns	NULL
and	NULL
PS	NULL
can	NULL
bind	NULL
to	NULL
members	NULL
of	NULL
the	NULL
class	NULL
B	NULL
scavenger	NULL
receptor	NULL
family	NULL
(	NULL
SR-BU	NULL
CLA-1	NULL
,	NULL
CD36	NULL
)	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
,	NULL
which	NULL
are	NULL
found	NULL
on	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Certain	NULL
lymphocyte	NULL
subsets	NULL
are	NULL
also	NULL
known	NULL
to	NULL
bind	NULL
both	NULL
PtdIns-	NULL
and	NULL
PS-containing	NULL
liposomes	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
extracellular	NULL
PtdIns	NULL
can	NULL
modulate	NULL
macrophage	NULL
functions	NULL
such	NULL
as	NULL
phagocytosis	NULL
(	NULL
28	NULL
)	NULL
.	NULL

A	NULL
role	NULL
for	NULL
lipid	NULL
transfer	NULL
proteins	NULL
in	NULL
these	NULL
phenomena	NULL
has	NULL
not	NULL
been	NULL
described	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
PtdIns	NULL
binds	NULL
to	NULL
mCD14	NULL
with	NULL
specificity	NULL
and	NULL
saturability	NULL
,	NULL
that	NULL
LBP	NULL
is	NULL
necessary	NULL
for	NULL
this	NULL
interaction	NULL
,	NULL
and	NULL
that	NULL
PtdIns	NULL
can	NULL
both	NULL
prevent	NULL
LPS-mCD14	NULL
binding	NULL
and	NULL
inhibit	NULL
LPS-induced	NULL
cellular	NULL
responses	NULL
.	NULL

The	NULL
results	NULL
suggest	NULL
that	NULL
Pt-dns	NULL
and	NULL
LPS	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
or	NULL
nearby	NULL
sites	NULL
on	NULL
mCD14	NULL
and	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
PtdIns	NULL
modulates	NULL
mCD14-dependent	NULL
responses	NULL
to	NULL
LPS	NULL
and	NULL
other	NULL
mCD14	NULL
ligands	NULL
in	NULL
vivo	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Lipids	NULL
and	NULL
Other	NULL
Reagents-Nonradioactive	NULL
lipids	NULL
and	NULL
related	NULL
compounds	NULL
were	NULL
purchased	NULL
from	NULL
Serdary	NULL
Laboratories	NULL
(	NULL
London	NULL
,	NULL
Ontario	NULL
)	NULL
(	NULL
egg	NULL
phosphatidylcholine	NULL
)	NULL
,	NULL
Avanti	NULL
Polar	NULL
Lipids	NULL
(	NULL
Alabaster	NULL
,	NULL
AL	NULL
)	NULL
(	NULL
liver	NULL
phosphatidylinositol	NULL
,	NULL
egg	NULL
phosphatidylglycerol	NULL
,	NULL
brain	NULL
phosphatidyl-serine	NULL
)	NULL
,	NULL
or	NULL
Sigma	NULL
(	NULL
nonradiolabeled	NULL
inositides	NULL
,	NULL
bovine	NULL
brain	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
)	NULL
.	NULL

Synthetic	NULL
dipalmitoylated	NULL
phosphatidylinositides	NULL
were	NULL
purchased	NULL
from	NULL
Echelon	NULL
Laboratories	NULL
(	NULL
Salt	NULL
Lake	NULL
City	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

1-Stearoyl-2-	NULL
[	NULL
'*Clarachido-nylphosphatidylinositol	NULL
(	NULL
26.7	NULL
mCi/mmol	NULL
)	NULL
,	NULL
1l-palmitoyl-2-	NULL
(	NULL
9,10-°HJ	NULL
palmitoylphosphatidylcholine	NULL
(	NULL
82.9	NULL
Ci/mmol	NULL
)	NULL
,	NULL
1-palmitoyl-2-	NULL
[	NULL
1-	NULL
``	NULL
``	NULL
'Clar-achidonylphosphatidylcholine	NULL
(	NULL
55	NULL
mCi/mmol	NULL
)	NULL
,	NULL
1l-palmitoyl-2-	NULL
[	NULL
1-	NULL
``	NULL
``	NULL
C	NULL
]	NULL
arachidonylphosphatidylethanolamine	NULL
(	NULL
54.6	NULL
mCi/mmol	NULL
)	NULL
,	NULL
dipalmitoyl	NULL
[	NULL
glycerol-U-'*C	NULL
)	NULL
phosphatidie	NULL
acid	NULL
(	NULL
144	NULL
mCi/mmol	NULL
)	NULL
,	NULL
and	NULL
[	NULL
9,10-acid	NULL
(	NULL
85.9	NULL
Ci/mmol	NULL
)	NULL
were	NULL
from	NULL
NEN	NULL
Life	NULL
Science	NULL
Products	NULL
,	NULL
and	NULL
1,2-dioleoylphosphatidyl-	NULL
[	NULL
'*C	NULL
]	NULL
serine	NULL
(	NULL
50	NULL
mCi/mmol	NULL
)	NULL
was	NULL
from	NULL
Am-ersham	NULL
Pharmacia	NULL
Biotech	NULL
.	NULL

Lipids	NULL
were	NULL
dried	NULL
under	NULL
argon	NULL
and	NULL
resuspended	NULL
by	NULL
sonication	NULL
in	NULL
10	NULL
mM	NULL
potassium	NULL
phosphate	NULL
,	NULL
140	NULL
mM	NULL
NaCl	NULL
,	NULL
or	NULL
SEBDAF	NULL
(	NULL
see	NULL
below	NULL
)	NULL
containing	NULL
1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
Sig-ma	NULL
)	NULL
.	NULL

Murine	NULL
TNF-a	NULL
«	NULL
was	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
Cells-Human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
were	NULL
carried	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
JRH	NULL
Biosciences	NULL
,	NULL
Lenexa	NULL
,	NULL
KS	NULL
)	NULL
,	NULL
and	NULL
where	NULL
indicated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
differentiated	NULL
to	NULL
express	NULL
mCD14	NULL
by	NULL
treatment	NULL
with	NULL
calcitriol	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
3	NULL
days	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Undifferentiated	NULL
mCD14-expressing	NULL
cells	NULL
were	NULL
produced	NULL
by	NULL
transfection	NULL
(	NULL
pRe/RSV-CD14-GPI	NULL
)	NULL
and	NULL
selected	NULL
for	NULL
G418	NULL
resistance	NULL
and	NULL
CD14	NULL
expression	NULL
by	NULL
fluorescence-acti-vated	NULL
cell	NULL
sorting	NULL
(	NULL
FACStar	NULL
``	NULL
``	NULL
>	NULL
,	NULL
Becton	NULL
Dickinson	NULL
Immunocytometry	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Control	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
(	NULL
pRe/RSV	NULL
)	NULL
and	NULL
selected	NULL
for	NULL
G418	NULL
resistance	NULL
(	NULL
25	NULL
)	NULL
.	NULL

To	NULL
minimize	NULL
ligand	NULL
internalization	NULL
during	NULL
binding	NULL
studies	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
=	NULL
7.4	NULL
,	NULL
140	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
NaF	NULL
,	NULL
300	NULL
ug/ml	NULL
BSA	NULL
,	NULL
10	NULL
mM	NULL
NaN	NULL
,	NULL
5	NULL
mM	NULL
deoxyglucose	NULL
)	NULL
for	NULL
80	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
before	NULL
ligands	NULL
were	NULL
added	NULL
.	NULL

Incubation	NULL
was	NULL
then	NULL
continued	NULL
for	NULL
15	NULL
min	NULL
before	NULL
the	NULL
cells	NULL
were	NULL
chilled	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
by	NULL
centrifugation	NULL
at	NULL
750	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
pul	NULL
248309	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
248310	NULL
a	NULL
PS	NULL
$	NULL
C	NULL
5	NULL
o	NULL
.	NULL

©	NULL
&	NULL
F	NULL
o	NULL
a	NULL
#	NULL
$	NULL
0	NULL
sof	NULL
el	NULL
E	NULL
a	NULL
.	NULL

40F	NULL
16:0	NULL
Ptdins	NULL
20	NULL
0	NULL
Co14	NULL
+	NULL
+	NULL
LBP	NULL
=	NULL
+	NULL
+	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Phospholipid	NULL
binding	NULL
to	NULL
mCD14	NULL
.	NULL

THP-1	NULL
cells	NULL
(	NULL
2.8	NULL
x	NULL
10°	NULL
in	NULL
50	NULL
pl	NULL
)	NULL
that	NULL
expressed	NULL
recombinant	NULL
mCD14	NULL
(	NULL
``	NULL
CD14	NULL
``	NULL
)	NULL
or	NULL
control	NULL
THP-1	NULL
cells	NULL
(	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
containing	NULL
the	NULL
indicated	NULL
radiolabeled	NULL
phospholipids	NULL
(	NULL
1	NULL
pM	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
0.07	NULL
ug/ml	NULL
LBP	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
phospholipid	NULL
bound	NULL
to	NULL
the	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

Bars	NULL
=	NULL
means	NULL
;	NULL
error	NULL
bars	NULL
=	NULL
maximal	NULL
values	NULL
of	NULL
duplicates	NULL
,	NULL
from	NULL
one	NULL
of	NULL
=	NULL
>	NULL
three	NULL
experiments	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

**	NULL
=	NULL
different	NULL
from	NULL
both	NULL
controls	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
.	NULL

PA	NULL
=	NULL
phosphatidic	NULL
acid	NULL
;	NULL
PE	NULL
=	NULL
phosphatidylethanolamine	NULL
;	NULL
PC	NULL
=	NULL
phatidylcholine	NULL
(	NULL
with	NULL
egg	NULL
phosphatidylcholine	NULL
added	NULL
to	NULL
=	NULL
1	NULL
pM	NULL
)	NULL
,	NULL
16:0	NULL
=	NULL
[	NULL
®H	NULL
]	NULL
palmitic	NULL
acid	NULL
(	NULL
with	NULL
nonradioactive	NULL
palmitate	NULL
added	NULL
to	NULL
=	NULL
1	NULL
pM	NULL
)	NULL
.	NULL

of	NULL
PBS	NULL
.	NULL

The	NULL
radioactivity	NULL
in	NULL
aliquots	NULL
of	NULL
the	NULL
suspended	NULL
cells	NULL
was	NULL
counted	NULL
using	NULL
a	NULL
Minaxi	NULL
Tricarh	NULL
4000	NULL
scintillation	NULL
counter	NULL
with	NULL
external	NULL
quench	NULL
standards	NULL
(	NULL
Packard	NULL
Instrument	NULL
Co.	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
counted	NULL
using	NULL
a	NULL
hemocytometer	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
(	NULL
15	NULL
units/ml	NULL
)	NULL
blood	NULL
by	NULL
centrifugation	NULL
onto	NULL
Histopaque	NULL
1077	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
RPMI	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
for	NULL
use	NULL
in	NULL
experiments	NULL
.	NULL

LPS-Tritiated	NULL
Escherichia	NULL
coli	NULL
LCD25	NULL
LPS	NULL
(	NULL
1500	NULL
°H	NULL
disintegra-tions/ng	NULL
)	NULL
was	NULL
produced	NULL
as	NULL
described	NULL
(	NULL
28	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Aliquots	NULL
were	NULL
suspended	NULL
in	NULL
HNEB	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
300	NULL
ug/ml	NULL
BSA	NULL
)	NULL
(	NULL
29	NULL
)	NULL
and	NULL
briefly	NULL
sonicated	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

Binding	NULL
of	NULL
LPS	NULL
to	NULL
cells	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Antibodies	NULL
and	NULL
Other	NULL
Reagents-Anti-CD14	NULL
mAbs	NULL
:	NULL
60bca	NULL
and	NULL
26ic	NULL
were	NULL
provided	NULL
by	NULL
Douglas	NULL
Golenbock	NULL
(	NULL
Boston	NULL
University	NULL
)	NULL
;	NULL
1H8-2C11	NULL
,	NULL
2G7-6B2-03	NULL
,	NULL
and	NULL
2G9-1G1	NULL
were	NULL
provided	NULL
by	NULL
Richard	NULL
Darveau	NULL
(	NULL
Bris-tol	NULL
Myers	NULL
Squibb	NULL
)	NULL
;	NULL
and	NULL
MY4	NULL
was	NULL
purchased	NULL
from	NULL
Coulter	NULL
(	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Murine	NULL
anti-human	NULL
LBP	NULL
mAb	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Peter	NULL
Tobias	NULL
(	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Sera	NULL
from	NULL
LBP	NULL
+/-	NULL
and	NULL
-/-	NULL
mice	NULL
were	NULL
also	NULL
provided	NULL
by	NULL
Dr.	NULL
Golenbock	NULL
(	NULL
80	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
LBP	NULL
and	NULL
control	NULL
medium	NULL
were	NULL
prepared	NULL
from	NULL
serum-free	NULL
medium	NULL
overlying	NULL
transfected	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
LBP	NULL
concentration	NULL
,	NULL
measured	NULL
with	NULL
an	NULL
ELISA	NULL
assay	NULL
using	NULL
antibodies	NULL
also	NULL
provided	NULL
by	NULL
Dr.	NULL
Tobias	NULL
,	NULL
was	NULL
0.7	NULL
pg/ml	NULL
.	NULL

Assays-IL-8	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
(	NULL
DuoSet	NULL
ELISA	NULL
Development	NULL
System	NULL
,	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
translocation	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Analysis-Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
each	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
or	NULL
more	NULL
times	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
and	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

Differences	NULL
in	NULL
group	NULL
means	NULL
were	NULL
analyzed	NULL
using	NULL
analysis	NULL
of	NULL
variance	NULL
(	NULL
Kwikstat	NULL
,	NULL
Texasoft	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Extracellular	NULL
PidIns	NULL
and	NULL
PS	NULL
Bind	NULL
to	NULL
mCD14-We	NULL
first	NULL
used	NULL
sonicated	NULL
suspensions	NULL
of	NULL
several	NULL
radiolabeled	NULL
lipids	NULL
to	NULL
study	NULL
mCD14-phospholipid	NULL
binding	NULL
.	NULL

Radiolabeled	NULL
lipids	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
were	NULL
added	NULL
to	NULL
metabolically	NULL
inhibited	NULL
THP-1	NULL
cells	NULL
that	NULL
expressed	NULL
either	NULL
recombinant	NULL
mCD14	NULL
or	NULL
no	NULL
recombinant	NULL
protein	NULL
(	NULL
vector-only	NULL
control	NULL
)	NULL
.	NULL

LBP-containing	NULL
medium	NULL
or	NULL
control	NULL
medium	NULL
was	NULL
also	NULL
added	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
approximately	NULL
5-fold	NULL
more	NULL
PtdIns	NULL
bound	NULL
to	NULL
the	NULL
cells	NULL
when	NULL
both	NULL
mCD14	NULL
and	NULL
LBP	NULL
were	NULL
present	NULL
(	NULL
5.6	NULL
+	NULL
1.8-fold	NULL
increase	NULL
above	NULL
control	NULL
,	NULL
n	NULL
=	NULL
12	NULL
)	NULL
.	NULL

LBP	NULL
did	NULL
not	NULL
increase	NULL
PtdIns	NULL
binding	NULL
to	NULL
cells	NULL
that	NULL
lacked	NULL
mCD14	NULL
.	NULL

Of	NULL
the	NULL
other	NULL
phospholipids	NULL
tested	NULL
,	NULL
only	NULL
PS	NULL
was	NULL
bound	NULL
by	NULL
the	NULL
cells	NULL
in	NULL
a	NULL
mCD14-	NULL
and	NULL
LBP-dependent	NULL
fashion	NULL
(	NULL
2.3	NULL
+	NULL
0.5-fold	NULL
increase	NULL
Anionic	NULL
Glycerophospholipids	NULL
Bind	NULL
to	NULL
Monocyte	NULL
CD14	NULL
4000	NULL
,	NULL
t	NULL
t	NULL
t	NULL
40	NULL
A	NULL
E	NULL
R	NULL
3	NULL
E2	NULL
I	NULL
Total	NULL
8	NULL
5	NULL
@	NULL
2000	NULL
u	NULL
,	NULL
30	NULL
a	NULL
,	NULL
°	NULL
2	NULL
3	NULL
@	NULL
C	NULL
in	NULL
$	NULL
2	NULL
g	NULL
ig	NULL
2000	NULL
}	NULL
Non-specific	NULL
||	NULL
%	NULL
820	NULL
&	NULL
.	NULL

2	NULL
L5	NULL
?	NULL

a	NULL
@	NULL
o	NULL
=O	NULL
1000	NULL
}	NULL
{	NULL
o	NULL
10	NULL
Specific	NULL
g	NULL
e	NULL
=	NULL
%	NULL
5	NULL
10	NULL
15	NULL
20	NULL
REE	NULL
EE	NULL
E	NULL
§	NULL
g	NULL
&	NULL
T	NULL
©	NULL
[	NULL
!	NULL

*CJPtdins	NULL
added	NULL
,	NULL
uM	NULL
ffi	NULL
£	NULL
3	NULL
s	NULL
p	NULL
a	NULL
a	NULL
9	NULL
o	NULL
£	NULL
A	NULL
k	NULL
5	NULL
$	NULL
o	NULL
§	NULL
2	NULL
2	NULL
2	NULL
B	NULL
cod	NULL
.	NULL

A.	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

PidIns-mCD14	NULL
binding	NULL
is	NULL
saturable	NULL
and	NULL
specific	NULL
.	NULL

A	NULL
,	NULL
mCD14-expressing	NULL
THP-1	NULL
cells	NULL
(	NULL
3.1	NULL
X	NULL
10°	NULL
in	NULL
50	NULL
pl	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
[	NULL
'*CJPtdIns	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
LBP	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LBP	NULL
was	NULL
considered	NULL
specific	NULL
binding	NULL
.	NULL

Error	NULL
bars	NULL
=	NULL
minimal	NULL
and	NULL
maximal	NULL
values	NULL
of	NULL
duplicates	NULL
;	NULL
the	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
times	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

B	NULL
,	NULL
synthetic	NULL
dipalmitoylated	NULL
phosphatidylinositide	NULL
inhibitors	NULL
.	NULL

mCD14-expressing	NULL
cells	NULL
(	NULL
8.2	NULL
X	NULL
10°	NULL
in	NULL
100	NULL
ul	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
LBP	NULL
(	NULL
0.07	NULL
ug/ml	NULL
)	NULL
and	NULL
the	NULL
different	NULL
inhibitors	NULL
(	NULL
10	NULL
pM	NULL
)	NULL
as	NULL
indicated	NULL
for	NULL
5	NULL
min	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

[	NULL
'	NULL
``	NULL
C	NULL
]	NULL
PtdIns	NULL
(	NULL
1	NULL
pM	NULL
)	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
10	NULL
min	NULL
before	NULL
total	NULL
binding	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Egg	NULL
PC	NULL
and	NULL
brain	NULL
PS	NULL
were	NULL
also	NULL
tested	NULL
.	NULL

Control	NULL
=	NULL
no	NULL
added	NULL
LBP	NULL
.	NULL

No	NULL
inhibitor	NULL
=	NULL
[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
without	NULL
a	NULL
competing	NULL
lipid	NULL
.	NULL

Bar	NULL
height	NULL
=	NULL
average	NULL
of	NULL
triplicates	NULL
;	NULL
error	NULL
bars	NULL
=	NULL
maximal	NULL
values	NULL
.	NULL

Each	NULL
observation	NULL
was	NULL
repeated	NULL
one	NULL
or	NULL
more	NULL
times	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

above	NULL
control	NULL
,	NULL
»	NULL
=	NULL
4	NULL
)	NULL
.	NULL

PC	NULL
and	NULL
PE	NULL
that	NULL
had	NULL
different	NULL
acyl	NULL
chain	NULL
compositions	NULL
(	NULL
dipalmitoyl	NULL
versus	NULL
l-palmitoyl	NULL
,	NULL
2-arachidonyl	NULL
)	NULL
gave	NULL
virtually	NULL
identical	NULL
results	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PidIns	NULL
Binding	NULL
to	NULL
mCD14	NULL
Is	NULL
Saturable	NULL
and	NULL
Specific-Since	NULL
the	NULL
greatest	NULL
mCD14-dependent	NULL
augmentation	NULL
in	NULL
phospholipid	NULL
binding	NULL
was	NULL
found	NULL
using	NULL
PtdIns	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
study	NULL
this	NULL
interaction	NULL
in	NULL
detail	NULL
.	NULL

To	NULL
estimate	NULL
the	NULL
apparent	NULL
affinity	NULL
with	NULL
which	NULL
mCD14	NULL
binds	NULL
PtdIns	NULL
,	NULL
mCD14-expressing	NULL
THP-1	NULL
cells	NULL
were	NULL
again	NULL
incubated	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
to	NULL
inhibit	NULL
ligand	NULL
internal-ization	NULL
.	NULL

Increasing	NULL
concentrations	NULL
of	NULL
[	NULL
'*CJPtdIns	NULL
were	NULL
added	NULL
for	NULL
10	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
LBP	NULL
(	NULL
0.07	NULL
pg/ml	NULL
or	NULL
~1	NULL
uM	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
LBP-dependent	NULL
PtdIns	NULL
binding	NULL
was	NULL
saturable	NULL
.	NULL

Half-maximal	NULL
binding	NULL
occurred	NULL
at	NULL
approximately	NULL
0.5-1.0	NULL
um	NULL
PtdIns	NULL
.	NULL

To	NULL
probe	NULL
the	NULL
basis	NULL
for	NULL
PtdIns-mCD14	NULL
binding	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
series	NULL
of	NULL
nonradioactive	NULL
structures	NULL
to	NULL
inhibit	NULL
this	NULL
interaction	NULL
.	NULL

In	NULL
10-fold	NULL
molar	NULL
excess	NULL
,	NULL
liver-derived	NULL
PtdIns	NULL
inhibited	NULL
[	NULL
'*CJPtdInsmCD14	NULL
binding	NULL
by	NULL
>	NULL
90	NULL
%	NULL
,	NULL
whereas	NULL
egg	NULL
PC	NULL
and	NULL
brain	NULL
PS	NULL
were	NULL
not	NULL
inhibitory	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
we	NULL
then	NULL
studied	NULL
the	NULL
inhibitory	NULL
potency	NULL
of	NULL
several	NULL
soluble	NULL
headgroup	NULL
analogs	NULL
,	NULL
we	NULL
found	NULL
that	NULL
[	NULL
'*CJPtdins-mCD14	NULL
binding	NULL
could	NULL
be	NULL
blocked	NULL
(	NULL
>	NULL
80	NULL
%	NULL
)	NULL
by	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
1-2-glycerophospho-o-myo-inositol-4-monophosphate	NULL
,	NULL
but	NULL
not	NULL
by	NULL
pL-myo-inositol	NULL
,	NULL
DL-myo-inositol-1-monophosphate	NULL
,	NULL
DL-myo-inositol-1,4-bisphosphate	NULL
,	NULL
-	NULL
L-2-glycerophospho-p-myo-inositol	NULL
,	NULL
or	NULL
glycerophosphoinositol-4,5-phosphate	NULL
(	NULL
<	NULL
40	NULL
%	NULL
inhi-bition	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
glycerophosphoinositol	NULL
4-phos-phate	NULL
inhibited	NULL
while	NULL
inositol-1,4-phosphate	NULL
did	NULL
not	NULL
,	NULL
these	NULL
results	NULL
implicate	NULL
the	NULL
glycerol	NULL
moiety	NULL
as	NULL
one	NULL
determinant	NULL
of	NULL
binding	NULL
specificity	NULL
.	NULL

To	NULL
test	NULL
the	NULL
role	NULL
of	NULL
headgroup	NULL
structure	NULL
in	NULL
the	NULL
context	NULL
of	NULL
uniform	NULL
acylation	NULL
of	NULL
the	NULL
glycerol	NULL
backbone	NULL
,	NULL
we	NULL
then	NULL
compared	NULL
a	NULL
series	NULL
of	NULL
dipalmitoylated	NULL
,	NULL
synthetic	NULL
PtdIns	NULL
derivatives	NULL
as	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
PtdIns	NULL
(	NULL
3	NULL
)	NULL
P	NULL
,	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
,	NULL
PtdIns	NULL
(	NULL
3,4	NULL
)	NULL
P	NULL
;	NULL
,	NULL
and	NULL
PtdIns	NULL
(	NULL
4,5	NULL
)	NULL
P	NULL
;	NULL
,	NULL
were	NULL
potent	NULL
inhibitors	NULL
of	NULL
[	NULL
'*CJPtdIns-mCD14	NULL
binding	NULL
(	NULL
>	NULL
90	NULL
%	NULL
inhibition	NULL
by	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
inhibitor	NULL
)	NULL
,	NULL
whereas	NULL
PtdIns	NULL
,	NULL
PtdIns	NULL
(	NULL
5	NULL
)	NULL
P	NULL
,	NULL
and	NULL
PtdIns	NULL
(	NULL
3,5	NULL
)	NULL
P	NULL
were	NULL
less	NULL
inhibitory	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
binding	NULL
specificity	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
glycerophosphoinositol	NULL
headgroup	NULL
and	NULL
that	NULL
phosphorylation	NULL
at	NULL
3-OH	NULL
or	NULL
4-OH	NULL
favors	NULL
binding	NULL
.	NULL

The	NULL
acylated	NULL
structures	NULL
were	NULL
more	NULL
potent	NULL
inhibitors	NULL
than	NULL
the	NULL
nonacylated	NULL
ones	NULL
,	NULL
in	NULL
keeping	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Anionic	NULL
Glycerophospholipids	NULL
Bind	NULL
to	NULL
Monocyte	NULL
CD14	NULL
CD14-expressing	NULL
cells	NULL
pmoles	NULL
[	NULL
``	NULL
*CJPidins	NULL
bound	NULL
per	NULL
10°	NULL
cells	NULL
2.5	NULL
AAA/m	NULL
?	NULL

0.0	NULL
0	NULL
10	NULL
20	NULL
30	NULL
Incubation	NULL
time	NULL
,	NULL
min	NULL
B	NULL
,	NULL
-	NULL
0.6	NULL
x	NULL
24	NULL
05	NULL
3	NULL
C	NULL
o	NULL
°C	NULL
a	NULL
®	NULL
0.4	NULL
o	NULL
m	NULL
5	NULL
<	NULL
38	NULL
0.3	NULL
£5	NULL
E	NULL
,	NULL
02	NULL
0.1	NULL
0.0	NULL
Control	NULL
6Obca	NULL
IgG1	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

PtdIns	NULL
binds	NULL
to	NULL
mCD14	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
serum	NULL
.	NULL

A	NULL
,	NULL
mCD14-expressing	NULL
or	NULL
control-transfected	NULL
THP-1	NULL
cells	NULL
(	NULL
8.2	NULL
%	NULL
10°	NULL
in	NULL
50	NULL
pl	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
RPMI	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

10	NULL
%	NULL
(	NULL
final	NULL
v/v	NULL
)	NULL
normal	NULL
human	NULL
serum	NULL
and	NULL
[	NULL
'*C	NULL
)	NULL
PtdIns	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
20	NULL
volumes	NULL
of	NULL
ice-cold	NULL
PBS	NULL
were	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
prior	NULL
to	NULL
scintillation	NULL
counting	NULL
.	NULL

Error	NULL
bars	NULL
=	NULL
minimal	NULL
and	NULL
maximal	NULL
values	NULL
of	NULL
duplicates	NULL
.	NULL

In	NULL
most	NULL
instances	NULL
,	NULL
the	NULL
bars	NULL
are	NULL
obscured	NULL
by	NULL
the	NULL
symbols	NULL
.	NULL

The	NULL
time	NULL
course	NULL
was	NULL
repeated	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
,	NULL
and	NULL
the	NULL
5-min	NULL
time	NULL
point	NULL
was	NULL
tested	NULL
an	NULL
additional	NULL
time	NULL
(	NULL
see	NULL
``	NULL
Results	NULL
``	NULL
)	NULL
.	NULL

B	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
PtdIns	NULL
(	NULL
10°	NULL
dpm	NULL
)	NULL
was	NULL
dried	NULL
under	NULL
argon	NULL
,	NULL
sonicated	NULL
in	NULL
85	NULL
ul	NULL
of	NULL
SEBDAF	NULL
buffer	NULL
containing	NULL
1	NULL
mg/ml	NULL
BSA	NULL
,	NULL
and	NULL
added	NULL
to	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
normal	NULL
human	NULL
serum	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
4	NULL
h	NULL
(	NULL
three	NULL
experiments	NULL
)	NULL
or	NULL
18	NULL
h	NULL
(	NULL
one	NULL
experiment	NULL
)	NULL
,	NULL
aliquots	NULL
(	NULL
20	NULL
%	NULL
of	NULL
final	NULL
volume	NULL
)	NULL
were	NULL
added	NULL
to	NULL
4-5	NULL
X	NULL
10°	NULL
calcitriol-differentiated	NULL
THP-1	NULL
cells	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
(	NULL
100	NULL
ul	NULL
final	NULL
volume	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

CD14-dependent	NULL
binding	NULL
was	NULL
measured	NULL
by	NULL
preincubating	NULL
the	NULL
cells	NULL
for	NULL
10	NULL
min	NULL
with	NULL
anti-CD14	NULL
mAb	NULL
60bea	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
with	NULL
control	NULL
mouse	NULL
IgGl	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

Data	NULL
from	NULL
the	NULL
two	NULL
incubation	NULL
times	NULL
were	NULL
similar	NULL
and	NULL
were	NULL
combined	NULL
for	NULL
analysis	NULL
.	NULL

**	NULL
=	NULL
different	NULL
from	NULL
controls	NULL
,	NULL
p	NULL
<	NULL
0.05.	NULL
with	NULL
a	NULL
role	NULL
for	NULL
hydrophobic	NULL
interactions	NULL
in	NULL
either	NULL
presentation	NULL
of	NULL
the	NULL
headgroup	NULL
or	NULL
in	NULL
binding	NULL
to	NULL
mCD14	NULL
.	NULL

PidIns	NULL
Binds	NULL
to	NULL
mCD14	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
Normal	NULL
Serum	NULL
;	NULL
LBP	NULL
Is	NULL
the	NULL
Major	NULL
Serum	NULL
PidIns	NULL
Transfer	NULL
Protein-Monocytes	NULL
and	NULL
neutrophils	NULL
,	NULL
the	NULL
principal	NULL
mCD14-expressing	NULL
cells	NULL
,	NULL
normally	NULL
are	NULL
found	NULL
in	NULL
blood	NULL
.	NULL

Normal	NULL
human	NULL
serum	NULL
contains	NULL
approximately	NULL
50-100	NULL
um	NULL
PtdIns	NULL
(	NULL
13-15	NULL
)	NULL
and	NULL
LBP	NULL
(	NULL
~7	NULL
ug/ml	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
PtdIns	NULL
can	NULL
bind	NULL
to	NULL
mCD14	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
when	NULL
[	NULL
'*C	NULL
]	NULL
JPt-dns	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
,	NULL
it	NULL
bound	NULL
rapidly	NULL
to	NULL
CD14-expressing	NULL
cells	NULL
but	NULL
not	NULL
to	NULL
control	NULL
cells	NULL
;	NULL
after	NULL
incubation	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
mCD14-expressing	NULL
cells	NULL
bound	NULL
5.3	NULL
+	NULL
1.6-fold	NULL
(	NULL
n	NULL
=	NULL
3	NULL
experiments	NULL
)	NULL
more	NULL
PtdIns	NULL
than	NULL
control	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
allowed	NULL
trace	NULL
amounts	NULL
(	NULL
approximately	NULL
4	NULL
pmol	NULL
)	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
PtdIns	NULL
to	NULL
equilibrate	NULL
with	NULL
normal	NULL
human	NULL
serum	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
then	NULL
added	NULL
aliquots	NULL
of	NULL
the	NULL
serum	NULL
(	NULL
10	NULL
%	NULL
of	NULL
the	NULL
final	NULL
volume	NULL
)	NULL
to	NULL
calcitriol-differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
se-rum-incubated	NULL
[	NULL
°H	NULL
]	NULL
PtdIns	NULL
retained	NULL
its	NULL
expected	NULL
mobility	NULL
when	NULL
analyzed	NULL
using	NULL
thin-layer	NULL
chromatography	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
molecules	NULL
were	NULL
not	NULL
altered	NULL
by	NULL
prolonged	NULL
incubation	NULL
in	NULL
serum	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
PtdIns	NULL
binding	NULL
to	NULL
the	NULL
CD14-expressing	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
CD14	NULL
but	NULL
not	NULL
by	NULL
isotype-matched	NULL
mouse	NULL
IgG	NULL
.	NULL

Although	NULL
only	NULL
0.2	NULL
%	NULL
of	NULL
the	NULL
tracer	NULL
became	NULL
cell-associated	NULL
in	NULL
a	NULL
CD14-dependent	NULL
manner	NULL
,	NULL
if	NULL
the	NULL
tracer	NULL
PH	NULL
]	NULL
PtdIns	NULL
reached	NULL
248311	NULL
37	NULL
3	NULL
&	NULL
3	NULL
B	NULL
a	NULL
2	NULL
s	NULL
®	NULL
24	NULL
g	NULL
o	NULL
az	NULL
,	NULL
&	NULL
.	NULL

2	NULL
T	NULL
o	NULL
a	NULL
0	NULL
1	NULL
a	NULL
0	NULL
.	NULL

LBP	NULL
+/-	NULL
LBP	NULL
-/-	NULL
pmole	NULL
[	NULL
14C	NULL
]	NULL
Ptdlns	NULL
bound	NULL
6	NULL
per	NULL
10.	NULL
cells	NULL
Cells	NULL
*~	NULL
No	NULL
CD1	NULL
mobis	NULL
-	NULL
mobi4	NULL
-	NULL
mobi4	NULL
Ab	NULL
quBP	NULL
|g+G1	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

LBP	NULL
transfers	NULL
PtdIns	NULL
to	NULL
mCD14	NULL
.	NULL

A	NULL
,	NULL
(	NULL
4	NULL
pM	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
serum	NULL
from	NULL
LBP	NULL
+/-	NULL
or	NULL
LBP	NULL
-/-	NULL
mice	NULL
and	NULL
mCD14-expressing	NULL
THP-1	NULL
cells	NULL
(	NULL
8.6	NULL
X	NULL
10°	NULL
in	NULL
50	NULL
ul	NULL
)	NULL
for	NULL
2.5	NULL
min	NULL
at	NULL
87°C	NULL
.	NULL

[	NULL
*CJPtdIns-cell	NULL
binding	NULL
was	NULL
then	NULL
measured	NULL
.	NULL

Results	NULL
are	NULL
combined	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
in	NULL
which	NULL
coded	NULL
serum	NULL
samples	NULL
from	NULL
two	NULL
mice	NULL
of	NULL
each	NULL
type	NULL
were	NULL
tested	NULL
in	NULL
duplicate	NULL
.	NULL

Bars	NULL
=	NULL
means	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
maximal	NULL
values	NULL
.	NULL

B	NULL
,	NULL
SEBDAF-treated	NULL
control-transfected	NULL
or	NULL
mCD14-expressing	NULL
cells	NULL
(	NULL
2.4	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
;	NULL
an	NULL
anti-LBP	NULL
mAb	NULL
or	NULL
control	NULL
mouse	NULL
IgG1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
during	NULL
this	NULL
incubation	NULL
.	NULL

[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
(	NULL
2	NULL
pM	NULL
)	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
87	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
binding	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

**	NULL
=	NULL
different	NULL
from	NULL
mCD14	NULL
without	NULL
anti-LBP	NULL
,	NULL
p	NULL
<	NULL
0.05.	NULL
equilibrium	NULL
with	NULL
the	NULL
endogenous	NULL
serum	NULL
PtdIns	NULL
(	NULL
50-100	NULL
um	NULL
)	NULL
,	NULL
one	NULL
may	NULL
estimate	NULL
that	NULL
approximately	NULL
1-2	NULL
pmol	NULL
of	NULL
PtdIns	NULL
bound	NULL
to	NULL
mCD14	NULL
on	NULL
one	NULL
million	NULL
cells	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
serum	NULL
LBP	NULL
in	NULL
PtdIns-mCD14	NULL
binding	NULL
,	NULL
we	NULL
tested	NULL
serum	NULL
from	NULL
LBP-deficient	NULL
(	NULL
-/-	NULL
)	NULL
and	NULL
LBP	NULL
-sufficient	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
(	NULL
30	NULL
)	NULL
.	NULL

[	NULL
*C	NULL
]	NULL
PtdIns-mCD14	NULL
binding	NULL
was	NULL
significantly	NULL
greater	NULL
in	NULL
serum	NULL
from	NULL
LBP	NULL
+/-	NULL
mice	NULL
than	NULL
in	NULL
serum	NULL
from	NULL
LBP	NULL
-/-	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
human	NULL
LBP	NULL
greatly	NULL
inhibited	NULL
PtdIns-mCD14	NULL
binding	NULL
when	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
was	NULL
the	NULL
source	NULL
of	NULL
the	NULL
transfer	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
LBP	NULL
is	NULL
the	NULL
major	NULL
transfer	NULL
protein	NULL
in	NULL
serum	NULL
that	NULL
facilitates	NULL
PtdIns-mCD14	NULL
binding	NULL
.	NULL

PidIns	NULL
Inhibits	NULL
LPS	NULL
Binding	NULL
to	NULL
mCD14	NULL
and	NULL
Blocks	NULL
LPS	NULL
Signaling-We	NULL
next	NULL
asked	NULL
whether	NULL
PtdIns	NULL
could	NULL
prevent	NULL
LPS	NULL
from	NULL
binding	NULL
to	NULL
mCD14	NULL
.	NULL

[	NULL
PHJLPS	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
CD14-expressing	NULL
THP-1	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
LBP	NULL
(	NULL
0.07	NULL
ug/ml	NULL
)	NULL
and	NULL
graded	NULL
concentrations	NULL
of	NULL
nonradioactive	NULL
PtdIns	NULL
,	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
,	NULL
or	NULL
PC	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
PtdIns	NULL
and	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
inhibited	NULL
[	NULL
°HJLPS	NULL
uptake	NULL
during	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
2	NULL
h.	NULL
(	NULL
Inhibition	NULL
was	NULL
incomplete	NULL
since	NULL
there	NULL
was	NULL
substantial	NULL
CD14-independent	NULL
uptake	NULL
of	NULL
LPS	NULL
and	NULL
phosphatidylinositides	NULL
by	NULL
live	NULL
cells	NULL
during	NULL
the	NULL
2	NULL
h	NULL
period	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiment	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
PtdIns	NULL
to	NULL
block	NULL
LPS-induced	NULL
IL-8	NULL
production	NULL
.	NULL

Fig	NULL
.	NULL

5B	NULL
shows	NULL
that	NULL
PtdIns	NULL
and	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
inhibited	NULL
IL-8	NULL
release	NULL
,	NULL
whereas	NULL
PC	NULL
did	NULL
not	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
also	NULL
performed	NULL
using	NULL
freshly	NULL
prepared	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

PtdIns	NULL
and	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
blocked	NULL
[	NULL
°HJLPS	NULL
cell	NULL
binding	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
a	NULL
5	NULL
uM	NULL
concentration	NULL
of	NULL
either	NULL
inhibitor	NULL
reduced	NULL
LPS-induced	NULL
cell	NULL
responses	NULL
by	NULL
10-100-fold	NULL
(	NULL
shift	NULL
in	NULL
dose-response	NULL
curve	NULL
,	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
whereas	NULL
PC	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
the	NULL
above	NULL
findings	NULL
,	NULL
PtdIns	NULL
also	NULL
inhibited	NULL
LPS-induced	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
of	NULL
PtdIns	NULL
was	NULL
specific	NULL
for	NULL
LPS	NULL
,	NULL
since	NULL
PtdIns	NULL
did	NULL
not	NULL
inhibit	NULL
TNF-o-in-duced	NULL
IL-8	NULL
production	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
in	NULL
THP-1	NULL
cells	NULL
or	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
248312	NULL
HJLPS	NULL
uptake	NULL
by	NULL
cells	NULL
,	NULL
dpm	NULL
woof	NULL
?	NULL

__________________________	NULL
|	NULL
800	NULL
400	NULL
IL-8	NULL
released	NULL
,	NULL
pg/ml	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
°6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
0	NULL
1	NULL
Phospholipid	NULL
added	NULL
,	NULL
uM	NULL
10000	NULL
t	NULL
t	NULL
t	NULL
r	NULL
7500	NULL
}	NULL
0000	NULL
===	NULL
gue	NULL
``	NULL
¥	NULL
0	NULL
5000	NULL
;	NULL
IL-8	NULL
,	NULL
pg/ml	NULL
2500	NULL
10041	NULL
10	NULL
%	NULL
102	NULL
107	NULL
10°	NULL
10	NULL
LPS	NULL
,	NULL
ng/ml	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

PtdIns	NULL
inhibits	NULL
LPS	NULL
uptake	NULL
and	NULL
LPS-induced	NULL
IL-8	NULL
se-cretion	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
mCD14-expressing	NULL
transfected	NULL
THP-1	NULL
cells	NULL
(	NULL
8.2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
with	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
LBP	NULL
(	NULL
0.07	NULL
ug/ml	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
liver	NULL
PtdIns	NULL
(	NULL
]	NULL
)	NULL
,	NULL
bovine	NULL
brain	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
(	NULL
&	NULL
)	NULL
,	NULL
or	NULL
egg	NULL
PC	NULL
(	NULL
¥	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
,	NULL
then	NULL
[	NULL
PHIJLPS	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
2	NULL
h.	NULL
A	NULL
,	NULL
after	NULL
washing	NULL
to	NULL
remove	NULL
unbound	NULL
[	NULL
°HJLPS	NULL
,	NULL
the	NULL
cell-associated	NULL
[	NULL
°HJLPS	NULL
was	NULL
measured	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

B	NULL
,	NULL
IL-8	NULL
was	NULL
measured	NULL
in	NULL
cell-free	NULL
supernatants	NULL
from	NULL
the	NULL
same	NULL
experiment	NULL
.	NULL

The	NULL
IL-8	NULL
released	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LPS	NULL
stimulation	NULL
has	NULL
been	NULL
subtracted	NULL
.	NULL

Error	NULL
bars	NULL
=	NULL
range	NULL
of	NULL
duplicate	NULL
values	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

C	NULL
,	NULL
human	NULL
mononuclear	NULL
cells	NULL
(	NULL
9	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
RPMI	NULL
that	NULL
contained	NULL
0.07	NULL
ug/ml	NULL
LBP	NULL
,	NULL
0.3	NULL
mg/ml	NULL
BSA	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
a	NULL
5	NULL
uM	NULL
concentration	NULL
of	NULL
the	NULL
indicated	NULL
lipid	NULL
.	NULL

The	NULL
indicated	NULL
concentrations	NULL
of	NULL
LPS	NULL
were	NULL
then	NULL
added	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
sedimented	NULL
,	NULL
and	NULL
IL-8	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
.	NULL

Symbols	NULL
are	NULL
as	NULL
indicated	NULL
for	NULL
A	NULL
and	NULL
B.	NULL
O	NULL
=	NULL
no	NULL
lipid	NULL
added	NULL
(	NULL
control	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

Error	NULL
bars	NULL
=	NULL
minimal	NULL
and	NULL
maximal	NULL
values	NULL
(	NULL
duplicates	NULL
)	NULL
.	NULL

Inhibition	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
dose-response	NULL
curve	NULL
to	NULL
the	NULL
right	NULL
.	NULL

IL-8	NULL
release	NULL
from	NULL
human	NULL
mononuclear	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
least	NULL
as	NULL
measured	NULL
in	NULL
these	NULL
assays	NULL
,	NULL
neither	NULL
PtdIns	NULL
nor	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
was	NULL
stimulatory	NULL
.	NULL

To	NULL
address	NULL
the	NULL
possibility	NULL
that	NULL
LPS	NULL
was	NULL
sequestered	NULL
by	NULL
interacting	NULL
with	NULL
PtdIns	NULL
in	NULL
the	NULL
medium	NULL
,	NULL
we	NULL
incubated	NULL
THP-1	NULL
cells	NULL
with	NULL
LBP	NULL
(	NULL
0.07	NULL
ug/ml	NULL
)	NULL
and	NULL
PtdIns	NULL
,	NULL
or	NULL
PC	NULL
(	NULL
100	NULL
um	NULL
)	NULL
LBP	NULL
for	NULL
15	NULL
min	NULL
,	NULL
washed	NULL
to	NULL
remove	NULL
unbound	NULL
lipid	NULL
,	NULL
and	NULL
added	NULL
[	NULL
PHJLPS	NULL
(	NULL
4	NULL
ng/ml	NULL
)	NULL
with	NULL
fresh	NULL
LBP	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Preincubation	NULL
with	NULL
PtdIns	NULL
decreased	NULL
LBP-dependent	NULL
LPS	NULL
binding	NULL
by	NULL
>	NULL
25	NULL
%	NULL
,	NULL
whereas	NULL
preincubation	NULL
with	NULL
PC	NULL
was	NULL
ineffective	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
coincubation	NULL
of	NULL
PtdIns	NULL
and	NULL
LPS	NULL
was	NULL
not	NULL
necessary	NULL
for	NULL
PtdIns	NULL
to	NULL
inhibit	NULL
LPS-mCD14	NULL
binding	NULL
.	NULL

Nonetheless	NULL
,	NULL
Anionic	NULL
Glycerophospholipids	NULL
Bind	NULL
to	NULL
Monocyte	NULL
CD14	NULL
PI	NULL
0	NULL
.3	NULL
1	NULL
3	NULL
1010	NULL
LPS	NULL
++	NULL
+++	NULL
PL	NULL
.o	NULL
%	NULL
%	NULL
-	NULL
-	NULL
&	NULL
+-~10	NULL
PC	NULL
.3	NULL
1	NULL
3	NULL
1010	NULL
-	NULL
TNF	NULL
ss	NULL
.s	NULL
.	NULL

g	NULL
%	NULL
LPS	NULL
+++	NULL
4	NULL
%	NULL
-	NULL
-	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

PtdIns	NULL
inhibits	NULL
LPS-induced	NULL
NF-KB	NULL
translocation	NULL
.	NULL

Calcitriol-differentiated	NULL
THP-1	NULL
cells	NULL
(	NULL
2.4	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
RPMI	NULL
that	NULL
contained	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
LBP	NULL
(	NULL
0.07	NULL
pg/ml	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
liver	NULL
PtdIns	NULL
or	NULL
egg	NULL
PC	NULL
(	NULL
pM	NULL
)	NULL
,	NULL
then	NULL
LPS	NULL
(	NULL
2	NULL
ng/ml	NULL
)	NULL
or	NULL
TNF-a	NULL
«	NULL
(	NULL
2	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
60	NULL
min	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
was	NULL
measured	NULL
in	NULL
nuclear	NULL
extracts	NULL
by	NULL
a	NULL
gel-shift	NULL
assay	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
location	NULL
of	NULL
NF-xB-bound	NULL
oligonucleotide	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

g0	NULL
100	NULL
]	NULL
S	NULL
-	NULL
90	NULL
c.	NULL
o	NULL
so	NULL
a	NULL
's	NULL
170	NULL
m	NULL
§	NULL
60	NULL
Ag	NULL
50	NULL
Liz	NULL
40	NULL
6	NULL
-	NULL
30	NULL
&	NULL
€	NULL
20	NULL
E	NULL
F	NULL
0	NULL
:	NULL
*	NULL
1:1-	NULL
a	NULL
§	NULL
o	NULL
%	NULL
\	NULL
<	NULL
<	NULL
§	NULL
g	NULL
€	NULL
9	NULL
,	NULL
0	NULL
o	NULL
-=	NULL
Z	NULL
W	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS	NULL
and	NULL
PtdIns	NULL
binding	NULL
to	NULL
mCD14	NULL
by	NULL
anti-CD14	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

CD14-expressing	NULL
THP-1	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
SEBDAF	NULL
buffer	NULL
and	NULL
incubated	NULL
at	NULL
87	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Murine	NULL
anti-CD14	NULL
mAbs	NULL
or	NULL
IgG1	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
(	NULL
12	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
(	NULL
1	NULL
M	NULL
)	NULL
or	NULL
[	NULL
°HJLPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
and	NULL
LBP	NULL
(	NULL
0.07	NULL
pg/ml	NULL
)	NULL
were	NULL
then	NULL
added	NULL
(	NULL
final	NULL
volume	NULL
=	NULL
52	NULL
pl	NULL
)	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
before	NULL
[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
and	NULL
[	NULL
°HJLPS	NULL
binding	NULL
were	NULL
measured	NULL
(	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

Binding	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percent	NULL
of	NULL
the	NULL
control	NULL
(	NULL
no	NULL
Ab	NULL
)	NULL
specific	NULL
binding	NULL
(	NULL
binding	NULL
with	NULL
LBP	NULL
-	NULL
binding	NULL
without	NULL
LBP	NULL
=	NULL
specific	NULL
binding	NULL
)	NULL
.	NULL

Light	NULL
shading	NULL
=	NULL
LPS	NULL
;	NULL
dark	NULL
shading	NULL
=	NULL
PtdIns	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
closely	NULL
similar	NULL
results	NULL
.	NULL

Krror	NULL
bars	NULL
=	NULL
S.E	NULL
.	NULL

of	NULL
triplicates	NULL
.	NULL

since	NULL
LPS	NULL
can	NULL
evidently	NULL
insert	NULL
into	NULL
liposomes	NULL
that	NULL
contain	NULL
PtdIns	NULL
(	NULL
9	NULL
)	NULL
,	NULL
this	NULL
process	NULL
may	NULL
influence	NULL
the	NULL
outcome	NULL
of	NULL
longer	NULL
term	NULL
experiments	NULL
such	NULL
as	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Monoclonal	NULL
Antibodies	NULL
That	NULL
Block	NULL
LPS-mCD14	NULL
Binding	NULL
Also	NULL
Block	NULL
PidIns-mCD14	NULL
Binding-We	NULL
next	NULL
asked	NULL
whether	NULL
mAbs	NULL
known	NULL
to	NULL
inhibit	NULL
(	NULL
or	NULL
not	NULL
to	NULL
inhibit	NULL
)	NULL
LPS-mCD14	NULL
binding	NULL
would	NULL
also	NULL
inhibit	NULL
PtdIns-mCD14	NULL
binding	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
inhibition	NULL
of	NULL
LPS-mCD14	NULL
binding	NULL
by	NULL
a	NULL
panel	NULL
of	NULL
anti-CD14	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Anionic	NULL
Glycerophospholipids	NULL
Bind	NULL
to	NULL
Monocyte	NULL
CD14	NULL
mAbs	NULL
closely	NULL
paralleled	NULL
inhibition	NULL
of	NULL
PtdIns-mCD14	NULL
binding	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
PtdIns	NULL
and	NULL
LPS	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
or	NULL
nearby	NULL
regions	NULL
of	NULL
mCD14	NULL
.	NULL

As	NULL
noted	NULL
above	NULL
,	NULL
binding	NULL
of	NULL
mCD14	NULL
by	NULL
LPS	NULL
,	NULL
PS	NULL
,	NULL
and	NULL
phos-phatidylinositides	NULL
,	NULL
like	NULL
most	NULL
other	NULL
ligands	NULL
,	NULL
is	NULL
greatly	NULL
facilitated	NULL
by	NULL
LBP	NULL
.	NULL

To	NULL
what	NULL
extent	NULL
is	NULL
the	NULL
specificity	NULL
of	NULL
phospholipid-mCD14	NULL
binding	NULL
actually	NULL
conferred	NULL
by	NULL
LBP	NULL
?	NULL

We	NULL
took	NULL
several	NULL
approaches	NULL
to	NULL
this	NULL
question	NULL
.	NULL

Doubling	NULL
the	NULL
LBP	NULL
concentration	NULL
in	NULL
the	NULL
reaction	NULL
mixtures	NULL
did	NULL
not	NULL
raise	NULL
the	NULL
saturating	NULL
concentration	NULL
of	NULL
PtdIns	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
phospholipids	NULL
previously	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
LBP	NULL
(	NULL
PC	NULL
,	NULL
PE	NULL
)	NULL
(	NULL
7	NULL
)	NULL
did	NULL
not	NULL
block	NULL
[	NULL
'*C	NULL
)	NULL
JPtdIns-mCD14	NULL
binding	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
inhibition	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
PtdIns-mCD14	NULL
binding	NULL
occurred	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
LBP	NULL
and	NULL
100	NULL
pum	NULL
liver	NULL
PtdIns	NULL
or	NULL
brain	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
,	NULL
washed	NULL
to	NULL
remove	NULL
unbound	NULL
phos-phatidylinositide	NULL
,	NULL
and	NULL
reincubated	NULL
with	NULL
[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
and	NULL
a	NULL
fresh	NULL
supply	NULL
of	NULL
LBP	NULL
(	NULL
25	NULL
%	NULL
inhibition	NULL
of	NULL
[	NULL
AC	NULL
]	NULL
JPtdIns-mCD14	NULL
binding	NULL
by	NULL
PtdIns	NULL
,	NULL
60	NULL
%	NULL
inhibition	NULL
by	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
,	NULL
no	NULL
inhibition	NULL
by	NULL
PC	NULL
;	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PtdIns	NULL
,	NULL
PtdIns	NULL
(	NULL
4	NULL
)	NULL
P	NULL
,	NULL
and	NULL
[	NULL
'*C	NULL
]	NULL
PtdIns	NULL
thus	NULL
compete	NULL
for	NULL
binding	NULL
a	NULL
cell-surface	NULL
receptor	NULL
,	NULL
most	NULL
likely	NULL
mCD14	NULL
.	NULL

Although	NULL
LBP	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
pattern	NULL
of	NULL
ligand-mCD14	NULL
binding	NULL
observed	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
binding	NULL
specificity	NULL
observed	NULL
is	NULL
determined	NULL
principally	NULL
by	NULL
mCD14	NULL
.	NULL

Our	NULL
experiments	NULL
focused	NULL
on	NULL
phosphatidylinositide-mCD14	NULL
interactions	NULL
,	NULL
yet	NULL
we	NULL
also	NULL
found	NULL
that	NULL
PS	NULL
can	NULL
bind	NULL
to	NULL
mCD14	NULL
in	NULL
an	NULL
LBP-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Although	NULL
in	NULL
our	NULL
assay	NULL
system	NULL
mCD14	NULL
binds	NULL
PS	NULL
with	NULL
lower	NULL
apparent	NULL
affinity	NULL
than	NULL
it	NULL
binds	NULL
PtdIns	NULL
(	NULL
a	NULL
10-fold	NULL
excess	NULL
of	NULL
PS	NULL
did	NULL
not	NULL
inhibit	NULL
PtdIns-mCD14	NULL
binding	NULL
)	NULL
,	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
PS	NULL
may	NULL
account	NULL
for	NULL
its	NULL
role	NULL
in	NULL
recognizing	NULL
apoptotic	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
LBP	NULL
should	NULL
enhance	NULL
this	NULL
interaction	NULL
and	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
mCD14	NULL
may	NULL
also	NULL
bind	NULL
PtdIns	NULL
exposed	NULL
on	NULL
apoptotic	NULL
cells	NULL
or	NULL
on	NULL
membrane	NULL
microvesicles	NULL
such	NULL
as	NULL
those	NULL
released	NULL
in	NULL
response	NULL
to	NULL
various	NULL
inflammatory	NULL
stimuli	NULL
(	NULL
34	NULL
)	NULL
.	NULL

We	NULL
thus	NULL
suggest	NULL
that	NULL
phosphatidylinositides	NULL
and	NULL
PS	NULL
are	NULL
more	NULL
likely	NULL
than	NULL
the	NULL
other	NULL
phospholipids	NULL
tested	NULL
to	NULL
be	NULL
natural	NULL
mCD14	NULL
ligands	NULL
.	NULL

Its	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
LPS	NULL
for	NULL
binding	NULL
mCD14	NULL
further	NULL
suggests	NULL
that	NULL
PtdIns	NULL
,	NULL
the	NULL
most	NULL
abundant	NULL
anionic	NULL
phospholipid	NULL
in	NULL
serum	NULL
,	NULL
could	NULL
modulate	NULL
cellular	NULL
responses	NULL
to	NULL
low	NULL
concentrations	NULL
of	NULL
LPS	NULL
(	NULL
and	NULL
possibly	NULL
other	NULL
exogenous	NULL
agonists	NULL
that	NULL
bind	NULL
mCD14	NULL
)	NULL
in	NULL
vivo	NULL
.	NULL

A	NULL
great	NULL
excess	NULL
of	NULL
PtdIns	NULL
is	NULL
required	NULL
to	NULL
inhibit	NULL
LPS	NULL
binding	NULL
to	NULL
mCD14	NULL
,	NULL
however	NULL
,	NULL
and	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
movement	NULL
of	NULL
PtdIns	NULL
between	NULL
cells	NULL
,	NULL
lipoproteins	NULL
,	NULL
and	NULL
other	NULL
carrier	NULL
molecules	NULL
in	NULL
blood	NULL
.	NULL

mCD14-bound	NULL
phosphatidylinositides	NULL
might	NULL
also	NULL
be	NULL
translocated	NULL
into	NULL
the	NULL
cell	NULL
to	NULL
participate	NULL
in	NULL
signaling	NULL
reactions	NULL
,	NULL
to	NULL
provide	NULL
a	NULL
source	NULL
of	NULL
intracellular	NULL
arachidonate	NULL
(	NULL
35	NULL
)	NULL
,	NULL
or	NULL
for	NULL
other	NULL
functions	NULL
(	NULL
23	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Identifying	NULL
mCD14	NULL
as	NULL
a	NULL
phosphatidylinositide	NULL
and	NULL
PS	NULL
receptor	NULL
raises	NULL
intriguing	NULL
questions	NULL
about	NULL
the	NULL
possible	NULL
functions	NULL
of	NULL
a	NULL
LBP-dependent	NULL
mechanism	NULL
by	NULL
which	NULL
myeloid	NULL
cells	NULL
can	NULL
bind	NULL
these	NULL
extracellular	NULL
phospholipids	NULL
.	NULL

24313	NULL
Acknowledgments-We	NULL
thank	NULL
Paul	NULL
Sternweis	NULL
for	NULL
advice	NULL
and	NULL
reagents	NULL
;	NULL
Doug	NULL
Golenbock	NULL
,	NULL
Richard	NULL
Darveau	NULL
,	NULL
and	NULL
Peter	NULL
Tobias	NULL
for	NULL
generously	NULL
providing	NULL
essential	NULL
reagents	NULL
;	NULL
and	NULL
Leon	NULL
Eidels	NULL
,	NULL
Michael	NULL
Roth	NULL
,	NULL
and	NULL
Richard	NULL
Gaynor	NULL
for	NULL
criticizing	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Dziarski	NULL
,	NULL
R.	NULL
,	NULL
Tapping	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
8680-8690	NULL
2	NULL
.	NULL

Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Soldau	NULL
,	NULL
K.	NULL
,	NULL
Kline	NULL
,	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Kato	NULL
,	NULL
K.	NULL
,	NULL
Martin	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
8011-3021	NULL
3	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ramos	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1481-1483	NULL
4	NULL
.	NULL

Savedra	NULL
,	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
Delude	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Ingalls	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Golenbock	NULL
,	NULL
D.	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
2549-2554	NULL
5	NULL
.	NULL

Sellati	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Bouis	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Darveau	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Pugin	NULL
,	NULL
J.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Gangloff	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Norgard	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
and	NULL
Radolf	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
5455-5464	NULL
6	NULL
.	NULL

Otterlei	NULL
,	NULL
M.	NULL
,	NULL
Sundan	NULL
,	NULL
A.	NULL
,	NULL
Skjak-Breck	NULL
,	NULL
G.	NULL
,	NULL
Ryan	NULL
,	NULL
L.	NULL
,	NULL
Smidsrod	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Espevik	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

61	NULL
,	NULL
1917-1925	NULL
.	NULL

Yu	NULL
,	NULL
B.	NULL
,	NULL
Hailman	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99	NULL
,	NULL
815-324	NULL
.	NULL

Schumann	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Leong	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Flaggs	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Gray	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1429-1431	NULL
9	NULL
.	NULL

Wurfel	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
3925-3934	NULL
10	NULL
.	NULL

Schromm	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Brandenburg	NULL
,	NULL
K.	NULL
,	NULL
Rietschel	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Flad	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
Carroll	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Seydel	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

899	NULL
,	NULL
267-271	NULL
11	NULL
.	NULL

Devitt	NULL
,	NULL
A.	NULL
,	NULL
Moffatt	NULL
,	NULL
0	NULL
.	NULL

D.	NULL
,	NULL
Raykundalia	NULL
,	NULL
C.	NULL
,	NULL
Capra	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Gregory	NULL
,	NULL
C.	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
892	NULL
,	NULL
505-509	NULL
12	NULL
.	NULL

Savill	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Nature	NULL
892	NULL
,	NULL
442-448	NULL
13	NULL
.	NULL

Cunnane	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Ho	NULL
,	NULL
S.-Y	NULL
.	NULL

,	NULL
Dore-Duffy	NULL
,	NULL
P.	NULL
,	NULL
Ells	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
and	NULL
Horrobin	NULL
.	NULL

D.	NULL
F	NULL
(	NULL
1989	NULL
)	NULL
Am	NULL
.	NULL

J	NULL
.	NULL

Industrial	NULL
Med	NULL
.	NULL

50	NULL
,	NULL
801-806	NULL
14	NULL
.	NULL

Bagdade	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Buchanan	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
Pollare	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Lithell	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Atherosclerosis	NULL
117	NULL
,	NULL
209-215	NULL
15	NULL
.	NULL

Watala	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Jozwiak	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Clin	NULL
.	NULL

Chim	NULL
.	NULL

Acta	NULL
188	NULL
,	NULL
211-220	NULL
16	NULL
.	NULL

Bradamante	NULL
,	NULL
S.	NULL
,	NULL
Barchiesi	NULL
,	NULL
E.	NULL
,	NULL
Barenghi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Zoppi	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

185	NULL
,	NULL
299-308	NULL
17	NULL
.	NULL

Breckenridge	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Palmer	NULL
,	NULL
F.	NULL
B.	NULL
St.	NULL
C.	NULL
(	NULL
1982	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
712	NULL
,	NULL
707-711	NULL
18	NULL
.	NULL

Schwendener	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Lagocki	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Rahman	NULL
,	NULL
Y.	NULL
E.	NULL
(	NULL
1984	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
772	NULL
,	NULL
93-101	NULL
19	NULL
.	NULL

Nishikawa	NULL
,	NULL
K.	NULL
,	NULL
Arai	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Inoue	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
5226-5231	NULL
20	NULL
.	NULL

Rigotti	NULL
,	NULL
A.	NULL
,	NULL
Acton	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Krieger	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16221-16224	NULL
21	NULL
.	NULL

Murao	NULL
,	NULL
K.	NULL
,	NULL
Terpstra	NULL
,	NULL
V.	NULL
,	NULL
Green	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Kondratenko	NULL
,	NULL
N.	NULL
,	NULL
Steinberg	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Quehenberger	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
17551-17557	NULL
22	NULL
.	NULL

Wadee	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Rabson	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

180	NULL
,	NULL
2271-2276	NULL
23	NULL
.	NULL

Wassef	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Roerdink	NULL
,	NULL
F.	NULL
,	NULL
Richardson	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Alving	NULL
,	NULL
C.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
2655-2659	NULL
24	NULL
.	NULL

Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Munford	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

1760	NULL
,	NULL
485-494	NULL
25	NULL
.	NULL

Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Munford	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
in	NULL
Endotoxin	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
(	NULL
Morrison	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Brade	NULL
,	NULL
H.	NULL
,	NULL
Opal	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Vogel	NULL
,	NULL
S.	NULL
,	NULL
eds	NULL
)	NULL
Marcel	NULL
Dekker	NULL
,	NULL
26	NULL
.	NULL

Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Munford	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
9904-9910	NULL
27	NULL
.	NULL

Kirkland	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
Finley	NULL
,	NULL
F.	NULL
,	NULL
Letureg	NULL
,	NULL
D.	NULL
,	NULL
Moriarty	NULL
,	NULL
A.	NULL
,	NULL
Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
24818-24823	NULL
28	NULL
.	NULL

Munford	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
DeVeaux	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Cronan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Rick	NULL
,	NULL
P.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
148	NULL
,	NULL
115-120	NULL
29	NULL
.	NULL

Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Munford	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
1920-1928	NULL
30	NULL
.	NULL

Wurfel	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Monks	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Ingalls	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Dedrick	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Delude	NULL
,	NULL
R.	NULL
,	NULL
Zhou	NULL
,	NULL
D.	NULL
,	NULL
Lamping	NULL
,	NULL
N.	NULL
,	NULL
Schumann	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Thieringer	NULL
,	NULL
R.	NULL
,	NULL
Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
and	NULL
Golenbock	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186	NULL
,	NULL
2051-2056	NULL
31	NULL
.	NULL

Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Soldau	NULL
,	NULL
K.	NULL
,	NULL
Hatlen	NULL
,	NULL
L.	NULL
,	NULL
Schumann	NULL
,	NULL
R.	NULL
,	NULL
Einhorn	NULL
,	NULL
G.	NULL
,	NULL
Mathison	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

16C	NULL
,	NULL
151	NULL
(	NULL
abstr	NULL
.	NULL
)	NULL

82	NULL
.	NULL

Wurfel	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Kunitake	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Lichenstein	NULL
,	NULL
H.	NULL
,	NULL
Kane	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
1025-1035	NULL
33	NULL
.	NULL

Pradhan	NULL
,	NULL
D.	NULL
,	NULL
Krahling	NULL
,	NULL
S.	NULL
,	NULL
Williamson	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schlegel	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
8	NULL
,	NULL
767-778	NULL
34	NULL
.	NULL

Satta	NULL
,	NULL
N.	NULL
,	NULL
Toti	NULL
,	NULL
F.	NULL
,	NULL
Feugeas	NULL
,	NULL
O.	NULL
,	NULL
Bohbot	NULL
,	NULL
A.	NULL
,	NULL
Dachary-Prigent	NULL
,	NULL
J.	NULL
,	NULL
Eschwage	NULL
,	NULL
V.	NULL
,	NULL
Hedman	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Freyssinet	NULL
,	NULL
J.-M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
8245-8255	NULL
35	NULL
.	NULL

Zoeller	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Wightman	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Anderson	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Raetz	NULL
,	NULL
C.	NULL
R.	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
17212-17220	NULL
36	NULL
.	NULL

Yu	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Bozza	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
Tzizik	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Gray	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Cassara	NULL
,	NULL
J.	NULL
,	NULL
Dvorak	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Weller	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

152	NULL
,	NULL
759-769	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Phosphatidylinositides	NULL
Bind	NULL
to	NULL
Plasma	NULL
Membrane	NULL
CD14	NULL
and	NULL
Can	NULL
Prevent	NULL
Monocyte	NULL
Activation	NULL
by	NULL
Bacterial	NULL
Lipopolysaccharide	NULL
Ping-yuan	NULL
Wang	NULL
,	NULL
Richard	NULL
L.	NULL
Kitchens	NULL
and	NULL
Robert	NULL
S.	NULL
Munford	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:24309-24313.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.38.24309	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/38/24309	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
35	NULL
references	NULL
,	NULL
21	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

